Technologies for individual genotyping: Detection of genetic polymorphisms in drug targets and disease genes

American Journal of PharmacoGenomics

Volumn 2, Issue 3, 2002, Pages 197-205

  Shi, Michael M ^a  

^a SEQUENOM INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; MICROSPHERE;

ALLELE; BIOMEDICAL ENGINEERING; DNA MICROARRAY; DNA SEQUENCE; DRUG TARGETING; FLUORESCENCE POLARIZATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MASS SPECTROMETRY; MEDICAL RESEARCH; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW;

EID: 0036397680     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200202030-00005     Document Type: Review

References (41)

1. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000 Sep; 26 (1): 76-80
2. Martin ER, Lai EH, Gilbert JR, et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 2000 Aug; 67 (2): 383-94
3. Roses AD. Pharmacogenomics and the practice of medicine. Nature 2000; 405: 857-65
4. Kleyn PW, Vesell ES. Genetic variation as a guide to drug development. Science 1998; 281: 1820-1
5. Weber WW. Pharmacogenetics. New York: Oxford University Press, 1997
6. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999; 286: 487-91
7. Sachse C, Brockmoller J, Bauer S, et al. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet 1997; 60: 284-95
8. Iyer L, Hall D, Das S, et al. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin Pharmacol Ther 1999; 65: 576-8
9. Martinez FD, Graves PE, Baldini M, et al. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100: 3184-8
10. Drazen JM, Yandava CN, Dube L, et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 1999; 22: 168-70
11. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis: the Regression Growth Evaluation Statin Study Group. N Engl J Med 1999; 338: 86-93
12. Durant J, Clevenbergh P, Halfon P, et al. Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet 1999; 353: 2195-9
13. Chaix-Couturier C, Holtzer C, Phillips KA, et al. HIV-1 drug resistance genotyping: a review of clinical and economic issues. Pharmacoeconomics 2000 Nov; 18 (5): 425-33
14. Shi MM, Bleavins MR, de la Iglesia FA. Technologies for detecting genetic polymorphisms in pharmacogenomics. Mol Diagnosis 1999; 4: 343-51
15. Nickerson DA, Kaiser R, Lappin S, et al. Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci U S A 1990 Nov; 87 (22): 8923-7
16. Baron H, Fung S, Aydin A, et al. Oiligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia. Nat Biotechnol 1996; 14: 1279-82
17. Hansen TS, Petersen NE, Iitia A, et al. Robust nonradioactive oligonucleotide ligation assay to detect a common point mutation in the CYP2D6 gene causing abnormal drug metabolism. Clin Chem 1995; 41: 413-8
18. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998; 95: 8170-4
19. Clegg RM. Fluorescence resonance energy transfer and nucleic acids. Methods Enzymol 1992; 211: 353-88
20. Shi MM, Myrand SP, Bleavins MR, et al. High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes. Mol Pathol 1999; 52: 295-9
21. Shi MM, Myrand SP, Bleavins MR, et al. High-throughput genotyping method for glutathione S-transferase T1 and M1 gene deletions using TaqMan probes. Res Commun Mol Pathol Pharmacol 1999: 103: 3-15
22. Tyagi S, Bratu DP, Kramer FR. Multicolor molecular beacons for allele discrimination. Nat Biotechnol 1998; 16: 49-53
23. Lyamichev V, Mast AL, Hall JG, et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol 1999; 17: 292-6
24. Kwiatkowski RW, Lyamichev V, de Arruda M, et al. Clinical, genetic, and pharmacogenetic applications of the Invader assay. Mol Diagn 1999; 4: 353-64
25. Huber S, McMaster KJ, Voelkerding KV. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A. J Mol Diagn 2000 Aug; 2 (3): 153-7
26. Mein CA, Barratt BJ, Dunn MG, et al. Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. Genome Res 2000 Mar; 10 (3): 330-43
27. Ronaghi M, Karamohamed S, Pettersson B, et al. Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 1996 Nov 1; 242 (1): 84-9
28. Nikiforov TT, Rendle RB, Goelet P, et al. Genetic bit analysis: a solid phase method for typing single nucleotide polymorphisms. Nucleic Acids Res. 1994 Oct 11; 22 (20): 4167-75
29. Chen X, Levine L, Kwok P-Y. Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res 1999; 9: 492-8
30. Ross P, Hall L, Smirnov I, et al. High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotechnol 1998: 16: 1347-51
31. Tang K, Fu D, Julien D, et al. Chip-based genotyping by mass spectrometry. Proc Natl Acad Sci USA 1999; 96: 10016-20
32. Buetow KH, Edmonson M, MacDonald R, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Prroc Natl Acad Sci USA 2001; 98: 581-4
33. Gabriel SB, Schaffner SF, Nguyen H. et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-9
34. Chee M, Yang R, Hubbell E. et al. Accessing genetic information with high-density DNA arrays. Science 1996: 274: 610-4
35. Lipshutz RJ, Fodor SPA, Gingeras TR, et al. High density synthetic oligonucleotide arrays. Nat Genet 1999 (Suppl); 21: 20-4
36. Hirschhorn JN, Sklar P, Lindblad-Toh K, et al. SBE-TAGS: an array-based method for efficient single-nucleotide polymorphism genotyping. Proc Natl Acad Sci U S A 2000 Oct 24; 97 (22): 12164-9
37. Wang DG, Fan JB, Siao CJ, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998; 280: 1077-82
38. Hacia JG, Fan JB, Ryder O, et al. Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet 1999; 22: 164-7
39. Fulton RJ, McDade RL, Smith PL, et al. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 1997 Sep; 43 (9): 1749-56
40. Dunbar SA, Jacobson JW. Application of the luminex LabMAP in rapid screening for mutations in the cystic fibrosis transmembrane conductance regulator gene: a pilot study. Clin Chem 2000 Sep; 46 (9): 1498-500
41. Ferguson JA, Steemers FJ, Walt DR. High-density fiber-optic DNA random microsphere array. Anal Chem 2000 Nov 15; 72 (22): 5618-24